NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 3026-3050 out of 3569.

<< < 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 > >>

Public Release: 21-Feb-2014
Nature Communications
The parasite that escaped out of Africa
An international team has traced the origin of the second-worst malaria parasite of humans to Africa. The closest genetic relatives of human Plasmodium vivax were found only in Asian macaques, leading researchers to believe that P. vivax originated in Asia. This study overturns that, finding that wild-living apes in central Africa are widely infected with parasites that, genetically, are nearly identical to human P. vivax.
National Institutes of Health, Penn Center for AIDS Research, Agence Nationale de Recherche sur le Sida

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 20-Feb-2014
Biological Psychiatry
Study in mice raises question: Could PTSD involve immune response to stress?
Chronic stress that produces inflammation and anxiety in mice appears to prime their immune systems for a prolonged fight, causing the animals to have an excessive reaction to a single acute stressor weeks later, new research suggests.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Jonathan Godbout
Jonathan.Godbout@osumc.edu
614-293-3456
Ohio State University

Public Release: 20-Feb-2014
NCI recommends the Wistar Institute receive $14.9 million support grant renewal
After an extensive review by a panel of top cancer experts, the National Cancer Institute rated The Wistar Institute Cancer Center as 'exceptional' and recommended renewal for Wistar's Support Grant with an award of $14.9 million over the next five years. The Grant funds the infrastructure and research support facilities that enable Wistar scientists to conduct their research.
NIH/National Cancer Institute

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute

Public Release: 20-Feb-2014
Gut
Dismantling pancreas cancer's armor
Pancreas cancer is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer 'veils' itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a spontaneous anti-tumor immune response.
NIH/National Cancer Institute, Giles W. and Elise G. Mead Foundation, Safeway Foundation, Jack and Sylvia Paul Fund, and others

Contact: Kristen Woodward
media@fredhutch.org
206-667-2210
Fred Hutchinson Cancer Research Center

Public Release: 20-Feb-2014
Neurobiology of Aging
Study in fruitflies strengthens connection among protein misfolding, sleep loss, and age
Pathways of aging and sleep intersect at the circuitry of a cellular stress response pathway, and that by tinkering with those connections, it may be possible to alter sleep patterns in the aged for the better -- at least in fruit flies.
NIH/National Heart, Lung, and Blood Institute, NIH/National Institute on Aging

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 20-Feb-2014
Proceedings of the National Academy of Sciences
Surprising culprit found in cell recycling defect
Researchers at Washington University School of Medicine in St. Louis have identified an unusual cause of the lysosomal storage disorder called mucolipidosis III, at least in a subset of patients. Unlike most genetic diseases that involve dysfunctional or missing proteins, the culprit is a normal protein that ends up in the wrong place.
National Institutes of Health

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Public Release: 20-Feb-2014
Researchers look for culprit behind oral health problems in HIV-positive patients
Researchers want to help HIV-positive patients live better by understanding why their essentially dormant infection is still wreaking havoc in their mouths.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 20-Feb-2014
Journal of Clinical Oncology
Hypnosis therapy shown to decrease fatigue levels in breast cancer patients
Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis, according to a study recently published in the Journal of Clinical Oncology.
NIH/National Cancer Institute, American Cancer Society

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 20-Feb-2014
Molecular Cell
Chemical chaperones have helped proteins do their jobs for billions of years
An ancient chemical, present for billions of years, appears to have helped proteins function properly since time immemorial.
National Institutes of Health, Howard Hughes Medical Institute

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan

Public Release: 20-Feb-2014
2014 Multidisciplinary Head and Neck Cancer Symposium
HPV-positive OPSCC patients nearly twice as likely to survive as HPV-negative patients
A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group studies 0129 or 0522 found that HPV-positive patients had a higher overall survival rate than HPV-negative patients (at two years post-treatment, 54.6 percent versus 27.6 percent, respectively), according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
NIH/National Cancer Institute, Bristol-Meyers Squibb

Contact: Michelle Kirkwood
michellek@astro.org
703-286-1600
American Society for Radiation Oncology

Public Release: 20-Feb-2014
Chemistry & Biology
Scientists find resistance mechanism that could impact antibiotic drug development
A new study by scientists from the Florida campus of the Scripps Research Institute has uncovered a mechanism of drug resistance. This knowledge could have a major impact on the development of a pair of highly potent new antibiotic drug candidates.
National Institutes of Health

Contact: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute

Public Release: 20-Feb-2014
2014 Multidisciplinary Head and Neck Cancer Symposium
Recurrent mouth and throat cancers less deadly when caused by virus, study shows
People with late-stage cancer at the back of the mouth or throat that recurs after chemotherapy and radiation treatment are twice as likely to be alive two years later if their cancer is caused by the human papillomavirus, new research led by a Johns Hopkins scientist suggests.
NIH/National Cancer Institute, Bristol-Myers Squibb

Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine

Public Release: 20-Feb-2014
Cell Reports
Molecular 'cocktail' transforms skin cells into beating heart cells
scientists at the Gladstone Institutes have devised a new method that allows for the more efficient -- and, importantly, more complete -- reprogramming of skin cells into cells that are virtually indistinguishable from heart muscle cells. These findings, based on animal models and described in the latest issue of Cell Reports, offer newfound optimism in the hunt for a way to regenerate muscle lost in a heart attack.
California Institute for Regenerative Medicine, National Institutes of Health, Roddenberry Foundation, William K. Bowes, Jr. Foundation

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes

Public Release: 20-Feb-2014
American Journal of Human Genetics
CHOP researcher co-leads study finding genes that affect blood pressure
A large international study has discovered 11 new genetic signals associated with blood pressure levels. Ten of those signals are 'druggable' -- in regions with genes encoding proteins that appear to be likely targets for existing drugs or drugs currently in development.
NIH/National Heart, Lung, and Blood Institute, British Heart Foundation, Netherlands Organisation for Health Research and Development

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia

Public Release: 19-Feb-2014
Psychology and Aging
Aging men: More uplifts, fewer hassles until the age of 65-70
A new study of how men approach their golden years found that how happy individuals are remains relatively stable for some 80 percent of the population, but perceptions of unhappiness -- or dealing with 'hassles' -- tends to get worse once you are about 65-70 years old. Possible causes are health issues, cognitive decline or the loss of a spouse or friends.
National Institutes of Health, Department of Veterans Affairs

Contact: Carolyn Aldwin
Carolyn.aldwin@oregonstate.edu
541-737-2024
Oregon State University

Public Release: 19-Feb-2014
Bioinformatics
Whole genome analysis, stat
Although the time and cost of sequencing an entire human genome has plummeted, analyzing the resulting three billion base pairs of genetic information can take months. Researchers working with Beagle -- one of the world's fastest supercomputers devoted to life sciences -- report they can analyze 240 full genomes in 50 hours.
National Institutes of Health, Doris Duke Charitable Foundation

Contact: John Easton
john.easton@uchospitals.edu
773-795-5225
University of Chicago Medical Center

Public Release: 19-Feb-2014
New England Journal of Medicine
Bevacizumab (Avastin) fails to improve survival for newly diagnosed glioblastoma patients
Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
NIH/National Cancer Institute

Contact: Karen Warmkessel
kwarmkessel@umm.edu
410-328-8919
University of Maryland Medical Center

Public Release: 19-Feb-2014
Nature
Gene sequencing project discovers common driver of a childhood brain tumor
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tumor development. The research appears Feb. 19 as an advanced online publication in the scientific journal Nature.
Pediatric Cancer Genome Project, Kay Jewelers, National Institutes of Health, Collaborative Ependymoma Research Network, ALSAC

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 19-Feb-2014
Leukemia
Infants with leukemia inherit susceptibility
Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that may make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.
Children's Discovery Institute, National Institutes of Health, NIH/National Cancer Institute, Alex's Lemonade Stand 'A' Award, Hyundai Hope Award

Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University School of Medicine

Public Release: 19-Feb-2014
Which asthma drugs, dosages work best for African Americans?
The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer much higher rates of serious asthma attacks, hospitalizations and asthma-related deaths than do white patients.
National Institutes of Health

Contact: Sharon Parmet
sparmet@uic.edu
312-413-2695
University of Illinois at Chicago

Public Release: 19-Feb-2014
JAMA
Antidepressant holds promise in treating Alzheimer's agitation
An antidepressant medication has shown potential in treating symptoms of agitation that occur with Alzheimer's disease and in alleviating caregivers' stress, according to a multi-site US-Canada study.
NIH/National Institute of Mental Health, NIH/National Institute on Aging

Contact: Kate Richards
media@camh.ca
416-595-6015
Centre for Addiction and Mental Health

Public Release: 19-Feb-2014
Journal of Allergy and Clinical Immunology
The nose knows in asthma
Nasal tissue samples may make genetic profiles of asthmatic patients more a more common and valuable tool to personalize therapy and guide research.
National Institutes of Health, and others

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health

Public Release: 19-Feb-2014
Nature
Rutgers scientists identify structure of virus that could lead to hepatitis C vaccine
Rutgers University scientists have determined the structure of a hepatitis C surface protein, a finding that could assist in the development of a vaccine to halt the spread of the the deadly disease that has infected 3.2 million Americans.
Yerkes Research Center, National Institutes of Health, New Jersey Commission on Cancer Research

Contact: Robin Lally
rlally@ucm.rutgers.edu
848-932-0557
Rutgers University

Public Release: 19-Feb-2014
Journal of Physical Activity and Health
New sitting risk: Disability after 60
If you're 60 and older, every additional hour a day you spend sitting is linked to doubling the risk of being disabled -- regardless of how much exercise you get, reports a new study. The study is the first to show sedentary behavior is its own risk factor for disability, separate from lack of moderate vigorous physical activity. In fact, sedentary behavior is almost as strong a risk factor for disability as lack of exercise.
National Institutes of Health

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 19-Feb-2014
Science Translational Medicine
Cell therapy shows remarkable ability to eradicate cancer in clinical study
The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
NIH/National Cancer Institute, Terry Fox Foundation, and others

Contact: Andrea Baird
bairda@mskcc.org
212-639-3573
Memorial Sloan Kettering Cancer Center

Showing releases 3026-3050 out of 3569.

<< < 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.